Racial Disparities in Prescriptions for Cardioprotective Drugs and Cardiac Outcomes in Veterans Affairs Hospitals
February 15th, 2010 Posted by: admin
Publication year: 2010
Source: The American Journal of Cardiology, In Press, Corrected Proof, Available online 13 February 2010
Jawahar L., Mehta , Zoran, Bursac , Paulette, Mehta , Darpan, Bansal , Louis, Fink , …
Previous reports have suggested that blacks receive life-saving cardioprotective therapies less often than whites, probably because of a lower socioeconomic status, which leads to poor access to physicians. We questioned whether racial disparity existed in the Veterans Affairs Healthcare System. We examined the Veterans’ Integrated Service Network (VISN 16) database with regard to the prescription rates for 4 cardiovascular agents—aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors. The database, encompassing 474,565 patients (117,071 blacks and 357,494 whites), was analyzed. Cardioprotective drugs were prescribed significantly less often to black patients than compared to white patients (β blockers 19.7% vs 24.8%, odds…
Similar Posts:
- Racial Disparities in Prescriptions for Cardioprotective Drugs and Cardiac Outcomes in Veterans Affairs Hospitals
- Incontinence Related to Management of Benign Prostatic Hypertrophy
- Blacks Have the Highest Rates of Obesity in the U.S.
- Blacks Have the Highest Rates of Obesity in the U.S.
- Blacks Have the Highest Rates of Obesity in the U.S.
- Impact of Alpha 1-Adrenergic Antagonist Use for Benign Prostatic Hypertrophy on Outcomes in Patients With Heart Failure
- Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: Results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study
- Swine Flu tracking on Qsurveillance
- Polypharmacy and health beliefs in older outpatients
- Impairment of Cognitive Abilities and Decision Making after Chronic Use of Alcohol: The Impact of Multiple Detoxifications